Showing 1 to 10 of 2,092
| Title | Reference number | Reference number sort | Published | Published date sort | Last updated | Last updated sort |
|---|---|---|---|---|---|---|
| Permanent His-bundle pacemaker implantation for treating heart failure | Reference number:IPG694 | IPG00694 | Published:05 May 2021 | 20210505 | Last updated:05 May 2021 | 20210505 |
| Personal KinetiGraph for remote clinical management of Parkinson’s disease | Reference number:MIB258 | MIB00258 | Published:04 May 2021 | 20210504 | Last updated:04 May 2021 | 20210504 |
| Axonics sacral neuromodulation system for faecal incontinence | Reference number:MIB259 | MIB00259 | Published:04 May 2021 | 20210504 | Last updated:04 May 2021 | 20210504 |
| UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia | Reference number:MTG58 | MTG00058 | Published:04 May 2021 | 20210504 | Last updated:04 May 2021 | 20210504 |
| Repetitive short-pulse transscleral cyclophotocoagulation for glaucoma | Reference number:IPG692 | IPG00692 | Published:28 April 2021 | 20210428 | Last updated:28 April 2021 | 20210428 |
| Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults | Reference number:IPG693 | IPG00693 | Published:28 April 2021 | 20210428 | Last updated:28 April 2021 | 20210428 |
| Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy | Reference number:TA692 | TA00692 | Published:28 April 2021 | 20210428 | Last updated:28 April 2021 | 20210428 |
| Olaparib plus bevacizumab for maintenance treatment of advanced ovarian, fallopian tube or primary peritoneal cancer | Reference number:TA693 | TA00693 | Published:28 April 2021 | 20210428 | Last updated:28 April 2021 | 20210428 |
| Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia | Reference number:TA694 | TA00694 | Published:28 April 2021 | 20210428 | Last updated:28 April 2021 | 20210428 |
| Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myeloma | Reference number:TA695 | TA00695 | Published:28 April 2021 | 20210428 | Last updated:28 April 2021 | 20210428 |